Skip to content
TrialScanner

NCT01590888

Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease

Phase 2CompletedATHELead

Registry record

Lead sponsor
Prana Biotechnology Limited
Conditions
Huntington Disease
Primary completion
Jul 2013Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01590888 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01590888: Effect of PBT2 in Patients... | TrialScanner